Bovine Besnoitiosis: An emerging disease in Europe

EFSA Journal 2010; 8(2):1499 [15 pp.]. doi:10.2903/j.efsa.2010.1499
European Food Safety Authority Acknowledgment EFSA wishes to thank the members of the Working Group on Besnoitiosis for the preparation of this EFSA scientific output: Mariano Domingo (Chair), Luis M. Ortega-Mora, Mo Salman, Marcus Doherr and EFSA’s staff member Ana Afonso for the support provided to this EFSA scientific output. Special thanks for providing relevant information used in the drafting of this document are due to G. Alvarez-García (UCM, Spain), G. Schares (FLI, Germany), B. Gottstein (UBern, Switzerland), P. Jacquiet (ENVT, France), A. Gentile (UBol., Italy), H. Cortes (UEvor., Portugal) and P. García-Lunar (UCM, Spain). Contact ahaw@efsa.europa.eu
Type: Statement of EFSA On request from: EFSA Question number: EFSA-Q-2009-00879 Approved: 28 January 2010 Published: 11 February 2010 Affiliation: European Food Safety Authority (EFSA), Parma, Italy
Abstract

The European Food Safety Authority (EFSA) asked the Panel on Animal Health and Welfare to deliver a scientific statement on bovine besnoitiosis. Recent epidemiological data confirm an increased number of cases and geographic expansion of besnoitiosis in cattle herds in some EU MS therefore bovine besnoitiosis should be considered an emerging disease in the EU. However many aspects of the epidemiology of bovine besnoitiosis remain uncertain including prevalence and incidence of infection and disease in endemic areas, routes of transmission and risk-factors associated to infection and disease. The infection caused by the cyst-forming apicomplexan parasite Besnoitia besnoiti can cause serious adverse effects both during the acute and chronic phases of disease. The Panel has highlighted the importance to raise awareness about this disease in particular with farmers and veterinarians regarding clinical signs and the known transmission routes. Epidemiological investigations in endemic areas in Europe are necessary to elucidate the importance of infected animals and the routes of transmission. Diagnostic tools need to be further developed and standardized to address unanswered questions related to the epidemiology and clinical progression of the disease. Appropriate measures and strategies to control of besnoitiosis need to be investigated using the available epidemiological information.

© European Food Safety Authority, 2010

Summary

The European Food Safety Authority (EFSA) asked the Panel on Animal Health and Welfare to deliver a scientific statement on Bovine Besnoitiosis.

Recent epidemiological data confirm an increased number of cases and geographic expansion of Besnoitiosis in cattle herds in some EU MS, therefore bovine Besnoitiosis should be considered an emerging disease in the EU. Many aspects of the epidemiology of bovine besnoitiosis remain uncertain including, prevalence and incidence of infection and disease in endemic areas, routes of transmission and risk-factors associated to infection and disease. It is suspected that B. besnoiti has a heteroxenous life cycle. The definitive host (DH) has not been identified. The relationship between B. besnoiti and other Besnoitia spp. from ungulates remains to be elucidated. Horizontal direct and indirect transmission seems to be responsible for the spread of the disease. Arthropods such as horseflies and deer flies may play a role by transmitting B. besnoiti mechanically from chronically or asymptomatic infected cattle. Wild ruminants and probably rodents should not be disregarded as reservoirs of the parasite.

The infection can cause serious adverse effects both during the acute and chronic phases that could compromise animal welfare. Bovine besnoitiosis has two distinct sequential clinical stages, namely, the acute anasarca stage, which is mainly associated with proliferation of endozoites in blood vessels, and the chronic scleroderma stage which is mainly associated with cyst formation. The severity of the disease may vary between mild and severe with possible deaths in seriously affected animals. Many infected animals remain asymptomatic and the only sign of the disease is the presence of cysts in sclera conjunctiva and/or vulval area in cows. A number of diagnostic tests such as cytology, histopathology, serology and PCR testing are available. There are not any effective drugs or vaccines available in Europe at present.

The Animal Health and Welfare Panel recommends that epidemiological investigations in endemic areas in Europe are necessary to elucidate the importance of infected animals and the routes of transmission. In this context, relevance of direct transmission through direct contact during natural mating should be evaluated. Moreover, entomological studies can be used to evaluate e.g. the abundance of stable flies (Stomoxys calcitrans) or tabanids during such surveys, addressing the potential role of these biting flies in transmission. Further studies are necessary to elucidate the role of wild ruminants and rodents as putative reservoirs of the parasite. The existence of a definitive host and its role in the epidemiology of bovine besnoitiosis should be studied. Furthermore, the relationship between B. besnoiti and other Besnoitia spp. isolated from ungulates (B. tarandii and B. caprae) should be investigated to assess the risk of infection for domesticated ruminants.Diagnostic tools need to be further developed and standardized.to address unanswered questions related to the epidemiology and clinical progression of the disease. Appropriate measures and strategies to control of Besnoitiosis need to be investigated using the available epidemiological information.
 

Keywords

Bovine besnoitiosis, Besnoitia besnoiti geographical distribution, transmission, epidemiology, clinical signs, diagnosis